Does BEXAROTENE Cause Hepatic cytolysis? 10 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Hepatic cytolysis have been filed in association with BEXAROTENE (Bexarotene). This represents 1.3% of all adverse event reports for BEXAROTENE.
10
Reports of Hepatic cytolysis with BEXAROTENE
1.3%
of all BEXAROTENE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Hepatic cytolysis From BEXAROTENE?
Of the 10 reports, 2 (20.0%) required hospitalization.
Is Hepatic cytolysis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEXAROTENE. However, 10 reports have been filed with the FAERS database.
What Other Side Effects Does BEXAROTENE Cause?
Drug ineffective (67)
Hypothyroidism (65)
Death (53)
Hypertriglyceridaemia (44)
Off label use (32)
Disease progression (28)
Blood cholesterol increased (27)
Malignant neoplasm progression (26)
Pruritus (24)
Nausea (22)
What Other Drugs Cause Hepatic cytolysis?
ACETAMINOPHEN (1,469)
ATORVASTATIN (681)
PEMBROLIZUMAB (601)
CARBOPLATIN (577)
METHOTREXATE (468)
SULFAMETHOXAZOLE\TRIMETHOPRIM (356)
PACLITAXEL (324)
ENOXAPARIN (307)
AMOXICILLIN (273)
VALACYCLOVIR (261)
Which BEXAROTENE Alternatives Have Lower Hepatic cytolysis Risk?
BEXAROTENE vs BEZAFIBRATE
BEXAROTENE vs BEZLOTOXUMAB
BEXAROTENE vs BGB-11417
BEXAROTENE vs BICALUTAMIDE
BEXAROTENE vs BICTEGRAVIR